Editor's Note In a ranking of over 3,000 hospitals done by the Lown Institute, a nonprofit and nonpartisan think tank in Needham, Massachusetts, researchers found that while inclusion is being prioritized at some hospitals, segregated healthcare markets remain in cities like New Orleans, St. Louis, and Detroit.  The findings were…

Read More

Editor's Note A new study suggests that someone's initial exposure to a specific COVID-19 variant shows some influence to their immune response to subsequent variants of SARS-CoV-2, the virus responsible for COVID-19, the University of Cambridge October 6 reports. The research, published by Science on October 6 and titled "Mapping…

Read More

Editor's Note An experimental vaccine designed by researchers at University of Southern California has been shown to prevent serious infections from drug-resistant pathogens, according to an October 2023 study published by Science Translational Medicine. In this study, titled "A protein-free vaccine stimulates innate immunity and protects against nosocomial pathogens," the…

Read More

Editor's Note A new report from cybersecurity provider Critical Insight notes that data breaches are continuing to pose major problems for healthcare systems, an August 2023 Business Wire press release reports. Already more than 40 million patients' medical information was reportedly involved in data breaches in 2023. Following are key…

Read More

Editor's Note Early symptoms of type 2 diabetes often go undetected, and late detection can lead to long-term complications, including heart disease, nerve damage, and retinopathy. Screening for type 2 diabetes in the emergency department could reveal thousands of previously undiagnosed cases each year, EurekAlert! October 3 reports.  These findings…

Read More

Editor's Note A new vaccine for respiratory syncytial virus (RSV) has been found to be effective against a range of variants, according to an August 2023 Science Translational Medicine research article titled, "The RSVPreF3-AS01 vaccine elicits broad neutralization of contemporary and antigenically distant respiratory syncytial virus strains." This research was…

Read More

Editor's Note Data from The Joint Commission on sentinel events—events that result in patient death or serious harm—for the first half of 2023 are out and look to be on par with last year’s all-time high numbers, Becker's Clinical Leadership October 2 reports. Data from 2022 showed events rising to…

Read More

Editor's Note October is a month of awareness for several causes, according to the US Department of Human Services (HHS) and the Mental Health Technology Transfer Center Network (MHTTC). Each month, the HHS highlights "National Health Observances" (NHOs), and October, it is raising awareness for health literacy, breast cancer, the…

Read More

Editor's Note A 58-year-old cancer patient in the UK who had all the organs in her pelvis removed in a necessary life-saving procedure is now participating in an ongoing research project aimed at improving similar cancer treatments and outcomes, BBC News September 20 reports. The patient had cancer affecting her…

Read More

Editor's Note This new study from the Cleveland Clinic found that use of COVID-19 antiviral drugs Paxlovid (nirmatrelvir) and Lagevrio (molnupiravir) reduces risk of hospitalization and death in high-risk patients with mild disease, even against Omicron subvariants. The findings were published in JAMA Network on September 21. The study included…

Read More